slotkoers
Shanghai S.E.
00:00:00 07-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,21
CNY
|
+1,20%
|
|
+2,43%
|
-26,27%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
4.143
|
6.635
|
5.361
|
4.737
|
3.886
|
3.879
|
Bedrijfswaarde
1 |
4.198
|
6.725
|
5.467
|
4.932
|
4.093
|
4.090
|
K/w-verhouding
|
97,6
x
|
120
x
|
-95,5
x
|
-45
x
|
-1.078
x
|
634
x
|
Dividendrendement
|
0,41%
|
0,28%
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
4,11
x
|
4,74
x
|
5,7
x
|
4,55
x
|
4,93
x
|
5,71
x
|
Bedrijfswaarde/omzet
|
4,16
x
|
4,8
x
|
5,81
x
|
4,74
x
|
5,19
x
|
6,02
x
|
Bedrijfswaarde/EBITDA
|
60,7
x
|
63,6
x
|
63
x
|
48,9
x
|
123
x
|
94,1
x
|
Bedrijfswaarde/FCF
|
87,2
x
|
-192
x
|
185
x
|
132
x
|
-179
x
|
26,1
x
|
FCF Yield
|
1,15%
|
-0,52%
|
0,54%
|
0,76%
|
-0,56%
|
3,83%
|
Price to Book
|
3,61
x
|
5,61
x
|
4,86
x
|
5,17
x
|
4,4
x
|
4,22
x
|
Aantal aandelen (in duizenden)
|
684.712
|
684.712
|
684.712
|
683.512
|
679.347
|
679.347
|
Referentieprijs
2 |
6,050
|
9,690
|
7,830
|
6,930
|
5,720
|
5,710
|
Datum van publicatie
|
19/04/19
|
24/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.008
|
1.400
|
940,3
|
1.041
|
789
|
679,7
|
EBITDA
1 |
69,2
|
105,7
|
86,75
|
100,9
|
33,17
|
43,49
|
Bedrijfsresultaat (EBIT)
1 |
44,46
|
81,26
|
62,38
|
75,91
|
8,631
|
3,406
|
Operationele Marge
|
4,41%
|
5,8%
|
6,63%
|
7,29%
|
1,09%
|
0,5%
|
Resultaat voor belastingen (EBT)
1 |
65,22
|
84,08
|
-36,44
|
-66,63
|
3,922
|
23,48
|
Nettowinst (verlies)
1 |
42,79
|
55,51
|
-55,83
|
-105,4
|
-3,61
|
5,963
|
Nettomarge
|
4,24%
|
3,97%
|
-5,94%
|
-10,12%
|
-0,46%
|
0,88%
|
WPA
2 |
0,0620
|
0,0810
|
-0,0820
|
-0,1540
|
-0,005306
|
0,009000
|
Free Cash Flow
1 |
48,14
|
-35,1
|
29,51
|
37,48
|
-22,85
|
156,6
|
FCF-marge
|
4,77%
|
-2,51%
|
3,14%
|
3,6%
|
-2,9%
|
23,04%
|
Kasstroomconversie (ebitda)
|
69,57%
|
-
|
34,02%
|
37,15%
|
-
|
360,1%
|
Kasstroomconversie (nettowinst)
|
112,51%
|
-
|
-
|
-
|
-
|
2.626,09%
|
Dividend per aandeel
2 |
0,0250
|
0,0270
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19/04/19
|
24/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
55,7
|
90,5
|
106
|
195
|
207
|
211
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,8044
x
|
0,8557
x
|
1,224
x
|
1,935
x
|
6,236
x
|
4,856
x
|
Free Cash Flow
1 |
48,1
|
-35,1
|
29,5
|
37,5
|
-22,8
|
157
|
ROE (netto-inkomsten/eigen vermogen)
|
4,1%
|
4,92%
|
-4,17%
|
-9,55%
|
0,07%
|
0,74%
|
ROA (netto-inkomsten/totale activa)
|
1,11%
|
2,13%
|
1,85%
|
2,37%
|
0,29%
|
0,12%
|
Totale activa
1 |
3.850
|
2.608
|
-3.022
|
-4.453
|
-1.264
|
5.127
|
Nettoactief per aandeel
2 |
1,680
|
1,730
|
1,610
|
1,340
|
1,300
|
1,350
|
Cashflow per aandeel
2 |
0,5200
|
0,4300
|
0,4500
|
0,4500
|
0,4600
|
0,5100
|
Capex
1 |
15,8
|
13,2
|
19,6
|
26,9
|
20,9
|
7,51
|
Capex/omzet
|
1,57%
|
0,94%
|
2,08%
|
2,59%
|
2,65%
|
1,1%
|
Datum van publicatie
|
19/04/19
|
24/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -26,27% | 396 mln. | | +20,69% | 43,57 mld. | | +20,70% | 22,7 mld. | | +11,68% | 14,32 mld. | | +11,51% | 13,42 mld. | | +44,41% | 11,83 mld. | | -9,32% | 6,98 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +12,33% | 5,51 mld. |
Generieke geneesmiddelen
|